baber/WOPTO huggingface dataset:
Patent CA-3174100-A1 (CA)
Inventor: MISHRA SHAWN
IPC: A61B5/00
Filed: 2021-03-22
Abstract: Des procédés, des systèmes, et des dispositifs sont décrits dans la description pour divers modes de réalisation d'utilisation d'un système d'analyse d'échantillon destiné à analyser un échantillon de fluide corporel provenant d'un utilisateur pour déterminer des paramètres associés à l'utilisateur notamment les états d'hydratation, de déshydratation, de réhydratation, de perte d'électrolyte, de bien-être, de récupération et similaires. Dans certains modes de réalisation, les procédés peuvent être mis en uvre au moyen d'un dispositif porté par son utilisateur et couplé à un système d'analyse d'échantillon conçu pour collecter un échantillon de fluide corporel, ainsi que pour mesurer et analyser le fluide corporel afin de déterminer une propriété du fluide corporel et/ou un paramètre physiologique/de bien-être (par exemple, le degré d'hydratation, les pertes d'électrolytes, le taux de transpiration, etc.) de l'utilisateur.
Patent CA-3174243-A1 (CA)
Title: Assays for the detection of sars-cov-2
Inventor: BRAMBATI CHIARA
IPC: C12Q1/70
Filed: 2021-03-31
Abstract: The present invention is directed to methods for assaying for the presence of SARS-CoV-2 in a sample, including a clinical sample, and to oligonucleotides, reagents and kits useful in such assays. In particular, the present invention is directed to such assays that are rapid, accurate and specific for the detection of SARS-CoV-2 using labeled oligonucleotides hybridizing to the ORFlab and/or S gene.
Patent CA-3175290-A1 (CA)
Title: Systems and methods for mechanical displacement of an esophagus
Inventor: DAOUD EMILE
IPC: A61M29/02
Filed: 2021-04-13
Abstract: An example assembly for use with a vacuum system and an esophageal positioning device esophageal positioning device includes an introducer, in which the esophageal positioning device includes a first segment and a second segment. The second segment is pivotally connected to the first segment. A gap portion of an outer tube of the introducer is defined along a longitudinal axis between a tube tip of the introducer and the distal end of the second segment of the esophageal positioning device when the esophageal positioning device is disposed within the introducer. The gap portion defines one or more radial vacuum holes.
Patent CA-3175295-A1 (CA)
Inventor: PRAVETONI MARCO
IPC: A61K31/4468
Filed: 2021-03-12
Abstract: This disclosure describes fentanyl haptens, a fentanyl hapten-carrier conjugate, methods of making the fentanyl hapten-carrier conjugate, and methods of using the fentanyl hapten-carrier conjugate including, for example, as a prophylactic vaccine to counteract toxicity from exposure to fentanyl, fentanyl derivatives, and fentanyl analogs. In some embodiments, the fentanyl hapten-carrier conjugate or a composition including the fentanyl hapten-carrier conjugate may be used in an anti-opioid vaccine.
Patent CA-3176715-A1 (CA)
Title: Inhibiteurs de cxcl8 destines a etre utilises dans le traitement de la covid-19
Inventor: ALLEGRETTI MARCELLO
IPC: A61K31/727
Filed: 2021-03-24
Abstract: La présente invention concerne des inhibiteurs de CXCL8 destinés à être utilisés dans le traitement de patients atteints de COVID-19 avec une pneumonie.
Patent CA-3178428-A1 (CA)
Title: Extension module of surface drill rig
Inventor: KAMARAINEN TIMO
IPC: E21B15/00
Filed: 2022-10-05
Abstract: An extension module of a surface drill rig comprising a floor and walls configured to form an internal space, a coupling interface configured to enable coupling of the extension module to the surface drill rig such that the internal space of the extension module is combined with an internal space of the surface drill rig and at least one tank for a drilling fluid having a fluid connection to a drilling process, wherein the extension module, when coupled with the surface drill rig, is configured to enable moving of the surface drill rig with the extension module.
Patent CA-3180167-A1 (CA)
Inventor: SONNENSCHEIN ELAZAR
IPC: G06F21/10
Filed: 2021-04-26
Abstract: A system for acquiring ultrasound images of internal organs of a human body comprises a scanner and at least one inertial measurement unit (IMU) associated therewith, and electronic components for wired or wireless communication with remote terminals, said system being secured against malicious attacks or interference with the help of hardware, software, or a combination of both.
Patent CA-3182263-A1 (CA)
Title: Collapsible canopy
Inventor: YUAN CHUNLIANG
IPC: E04H15/46
Filed: 2021-06-10
Abstract: Disclosed is a foldable tent. The foldable tent includes a central lock, peripheral assemblies, and a plurality of inner telescopic units connected between the central lock and the peripheral assemblies. The central lock includes a central rod, a bottom cap and a locking mechanism. The locking mechanism is provided between the top cap and the central rod, such that the structure of the locking mechanism is simplified; a locking or unlocking operation can be conveniently performed at the bottom of the central lock; the central rod has a length that is not limited by a tent folding structure any more, and can be extended upwardly to elevate a canopy.
Patent CA-3184544-A1 (CA)
Inventor: SOMMERFELD MARK
IPC: A61P25/02
Filed: 2020-07-02
Abstract: The present invention relates to Glucagon-Like Peptide-1 Receptor (GLP-1R) agonistic peptides with reduced GLP-1R agonistic activity, and fusion molecules comprising the same. The present invention also relates to nucleic acid molecules encoding GLP-1R agonistic peptides with reduced GLP-1R agonistic activity, pharmaceutical compositions and combinations comprising GLP-1R agonistic peptides with reduced GLP-1R agonistic activity, and kits including GLP-1R agonistic peptides with reduced GLP-1R agonistic activity. The present invention further relates to the use of GLP-1R agonistic peptides with reduced GLP-1R agonistic activity as medicaments, in particular, for the treatment of obesity, being overweight, metabolic syndrome, diabetes mellitus, diabetic retinopathy, hyperglycemia, dyslipidemia, NASH and/or atherosclerosis.
Patent CA-3187107-A1 (CA)
Title: Fuse and associated manufacturing process
Inventor: MILLIERE LAURENT
IPC: H01H85/38
Filed: 2021-07-28
Abstract: Disclosed is a fuse comprising at least one fuse link (4) formed in a sheet having two opposite main faces extending along a longitudinal axis (A2) of the fuse link, each fuse link comprising a portion in which a reduced section (46A), defining a plane (P4) transverse to the fuse link, is provided. The fuse further includes arc barriers (6), which are made of a preformed elastic material and are associated in pairs (60), each of the arc barriers of a single pair being located opposite the other on a respective main face of a single fuse link. For at least a first pair (60) of arc barriers (6), an adhesive layer (72) is interleaved between the fuse link (4) and an inner face (66) of each arc barrier (6) of this pair, the inner face being oriented towards one of the main faces of the fuse link, so as to fasten each arc barrier onto the fuse link.
Patent CA-3193748-A1 (CA)
Title: Low capital and operational cost e-commerce logistics system
Inventor: FISCHMANN FERNANDO BENJAMIN
IPC: G06Q50/28
Filed: 2021-09-03
Abstract: The present invention discloses a disruptive low capital and operational cost logistics system and method that provides for fast and massive delivery of e-commerce merchandise, including same day delivery, of thousands of items and packages, in extensive geographical areas, such as whole states, countries and continents, reducing the need for building, operating, or using multiple fulfillment warehouses located near the consumers as in traditional e-commerce logistics, creating a revolution in the e-commerce industry worldwide.
Patent CA-3198368-A1 (CA)
Inventor: BEE JARED
IPC: A61K48/00
Filed: 2021-10-06
Abstract: Provided herein are pharmaceutical compositions for administration to a suprachoroidal space of an eye of a subject. The pharmaceutical compositions can include a recombinant adeno-associated virus (AAV) encoding a transgene. Also provided herein are methods for treating or preventing a disease in a subject by administering a therapeutically effective amount of the pharmaceutical compositions to the subject in need.
Patent CA-3199248-A1 (CA)
Title: Poignee pour instrument de soins personnels et accessoire de soins personnels
Inventor: JUNGNICKEL UWE
IPC: A46B5/02
Filed: 2021-11-04
Abstract: Une poignée pour un instrument de soins personnels comprend un connecteur pour fixer et détacher de manière répétée une tête à et à partir de la poignée, la poignée comprenant en outre une structure de noyau, la structure de noyau et le connecteur étant réalisés d'un seul tenant pour former une unité de connecteur de noyau, l'unité de connecteur de noyau étant constituée d'un matériau renforcé par des fibres.
Patent CA-3206268-A1 (CA)
Inventor: TROTTER MATTHEW WILLIAM BURNELL
IPC: G01N33/48
Filed: 2014-12-05
Abstract: Provided herein, in some embodiments, are methods of using certain cereblon -associated proteins, such as Aiolos, Ikaros, interferon (IFN), and IFN pathway proteins, casein kinase 1, alpha 1 (CSNK1A1), and ZFP9, as biomarkers for use in predicting and monitoring clinical sensitivity and therapeutic response to certain compounds in patients having various diseases and disorders, such as cancers (e.g., diffuse large B-cell lymphoma (DLBCL), multiple myeloma (MM), myelodysplasia syndromes (MDS) and acute myeloid leukemia (AML)) and IFN-associated disorders. Also provided herein, in certain embodiments, are methods of determining the efficacy of an immunomodulatory compound.
Patent CA-3206294-A1 (CA)
Inventor: KELLOGG RAWDON W
Filed: 2013-09-30
Abstract: A system, method and computer program product for interfacing a decision engine and a marketing engine in order to provide vendor-related data in response to decision-related data is disclosed. In at least one embodiment, the system and method may include providing a decision engine on a user-accessible network; interfacing a marketing engine with the decision engine on the network; receiving a plurality of user inputs with the decision engine; processing decision-related data with the decision engine in accordance with the plurality of user inputs; sharing the decision-related data with the marketing engine; processing the decision-related data with the marketing engine; and transmitting vendor-related data via the network.
Patent CA-3207064-A1 (CA)
Inventor: CHENG KANGGUO
IPC: H10B63/10
Filed: 2022-03-29
Abstract: Une cellule de mémoire à changement de phase (PCM) comprend une première électrode, un dispositif de chauffage connecté électriquement à la première électrode, un matériau PCM électriquement connecté au dispositif de chauffage, une seconde électrode connectée électriquement au matériau PCM, et un revêtement résistif en contact direct avec une paroi latérale du dispositif de chauffage et le matériau PCM et électriquement connecté à ceux-ci.
Patent CA-3207371-A1 (CA)
Inventor: XIANG BIN
IPC: A23C9/13
Filed: 2022-02-08
Abstract: L'invention concerne une bactérie intestinale probiotique génétiquement modifiée, comprenant une cassette d'expression exogène comprenant une séquence nucléotidique qui code l'acétaldéhyde déshydrogénase, la bactérie intestinale probiotique étant une souche d'Escherichia coli Nissle 1917 (EcN), ainsi que des utilisations associées.
Patent CA-3208430-A1 (CA)
Title: Pharmaceutical composition comprising anti-tigit antibody and anti-pd-1/anti-vegfa bispecific antibody, and use thereof
Inventor: XIA YU
Filed: 2023-02-14
Abstract: The present invention relates to the field of pharmaceuticals, particularly to an anti-TIGIT antibody, a pharmaceutical composition, and use thereof, and more particularly to use in combination with an anti-PD-1/anti-VEGFA antibody in preventing or treating a tumor. Specifically, the present invention relates to an anti-TIGIT antibody or an antigen-binding fragment thereof, wherein the antibody comprises a heavy chain variable region comprising HCDR1-HCDR3 having amino acid sequences set forth in SEQ ID NOs: 3-5, respectively; and the antibody comprises a light chain variable region comprising LCDR1-LCDR3 having amino acid sequences set forth in SEQ ID NOs: 8-10, respectively. The antibody of the present invention can effectively bind to TIGIT and has the potential for use in tumor prevention and treatment.
Patent CA-3210300-A1 (CA)
Inventor: LINDSAY SHANEL A
IPC: A24F13/06
Filed: 2022-02-01
Abstract: An odor containment and elimination device includes a containment center, first pathway, second pathway, and third pathway. The containment center can be configured to receive an odorous item that emits a contaminated air including an odor. The first pathway can be in fluid communication with the containment center and an outside environment and configured to allow contaminated air to travel from the containment center to a first release point while inhibiting seeping of the contaminated air from the first pathway into the outside environment prior to the first release point. The second pathway can be in fluid communication with the containment center and the outside environment via a first intake. The third pathway can be in fluid communication with the containment center and the outside environment and configured to reduce contaminated air released into the environment and/or direct the contaminated air through a door or window.
Patent CA-3211753-A1 (CA)
Title: Method for generating a virtual geometry, and system for data processing
Inventor: GANSER PHILIPP
IPC: G05B19/418
Filed: 2022-03-09
Abstract: The invention relates to a method, in particular a computer-implemented method, for generating a virtual geometry (32), a method for generating a digital twin, a system for data processing, and a computer program. The invention in particular relates to a method, in particular a computer-implemented method, for generating a virtual geometry of a component (8) which is produced or is intended to be produced by means of a machine tool (2) and which has a target geometry, comprising the steps: ascertaining tool information (12, 14) characterizing at least one tool parameter of the machine tool (2) influencing the geometry of the component (8); determining (230, 240, 250) at least one component factor (30) on the basis of the tool information (12, 14) and the target geometry (10); and generating (260), on the basis of the component factor (30), a first virtual geometry (32) as a digital geometric image of the component (8) which is produced or is intended to be produced.
Patent CA-3211902-A1 (CA)
Inventor: DEROSA FRANK
IPC: C07D319/12
Filed: 2015-05-29
Abstract: The present invention provides, in part, a biodegradable compound of formula I, and sub- formulas thereof:For-mula (I) or a pharmaceutically acceptable salt thereof, where each X independently is 0 or S, each Y independently is 0 or S, and each R1 independently is defined herein; and a lipo-sorne cornposition cornprising the cationic lip-id of formula I or a sub-formula thereof, and methods of delivering agents, such as nucleic acids including mRNA, in vivo, by administer-ing to a subject the liposome comprising the cationic lipid of formula 1 or a sub-formula thereof, where the agent is encapsulated within the liposome.
Patent CA-3213814-A1 (CA)
Inventor: TAN JIE
IPC: H04W76/28
Filed: 2021-03-26
Abstract: L'invention concerne des systèmes, un appareil et des procédés pour une communication sans fil, et plus précisément des techniques relatives à une réception discontinue (DRX), une heure avancée (DST) et des secondes intercalaires. Un procédé donné à titre d'exemple pour une communication sans fil consiste à déterminer un cycle de radiomessagerie cible associé à un dispositif sans fil sur la base du fait qu'une valeur de DRX étendue est configurée ou non. Un autre procédé donné à titre d'exemple pour une communication sans fil consiste à recevoir, en provenance d'un dispositif réseau, à un premier instant antérieur à un second instant, un message d'interface comprenant des informations temporelles ; et à ajuster, à un second instant, une heure locale sur la base des informations temporelles.
Patent CA-3216274-A1 (CA)
Inventor: TANHA JAMSHID
IPC: C07K16/10
Filed: 2022-04-22
Abstract: Described herein are antibodies that specifically recognize the SARS-CoV-2 spike (S) polypeptide,compositions comprising said antibodies, uses thereof, and methods employing said antibodies. Eachantibody specifically recognizes the S1-RBD domain, S1-NTD domain, or S2 subunit of the SARS-CoV-2 spike polypeptide. Some antibodies are cross-reactive with variants of SARS-CoV-2 and othercoronavirus spike polypeptides, such as SARS-CoV S, pangolin CoV S, bat SARS-like CoV S, andcivet SARS-CoV S.
Patent CA-3218080-A1 (CA)
Title: Hydraulic down-the-hole hammer and subsea pile
Inventor: KESKINIVA MARKKU
IPC: E21B4/14
Filed: 2022-04-28
Abstract: The present invention relates to a hydraulic down-the-hole hammer. The hammer comprises an elongate shaft and a piston having a central bore therethrough, the piston slidably mounted for reciprocal movement on the shaft and arranged to impact a percussion bit. Forward and rear drive chambers for the piston are disposed between the piston and the shaft and the forward chamber is separated from the rear chamber by an annular shoulder formed internally of the piston bore. The hammer also comprises a control valve to control reciprocation of the piston, wherein the control valve is arranged within the central bore of the piston. The hammer may be a disposable water hammer in which the piston is an outermost component of the hammer. The invention also relates to a method and system for installing a load-bearing element in a seabed, a method and system for installing a subsea anchor on a seabed, a subsea pile and a subsea anchor.
Patent CA-3219309-A1 (CA)
Title: Method for preparing anidulafungin derivative
Inventor: JIANG WEI
IPC: C07K7/56
Filed: 2022-06-02
Abstract: The present disclosure relates to a method for preparing an anidulafungin derivative. In particular, the present disclosure relates to a method for preparing an anidulafungin derivative as represented by formula (I) and an intermediate thereof.
Patent CA-3221129-A1 (CA)
Title: Forme cristalline du tolebrutinib, son procede de preparation et son utilisation
Inventor: CHEN MINHUA
IPC: C07D471/04
Filed: 2022-06-02
Abstract: La présente invention concerne une nouvelle forme cristalline du tolebrutinib (désigné ci-après "composé I"), son procédé de préparation, une composition pharmaceutique contenant la forme cristalline, et son utilisation dans la préparation d'un médicament inhibiteur de BTK et d'un médicament pour le traitement de la sclérose en plaques. La forme cristalline du tolebrutinib présente une ou plusieurs propriétés améliorées par rapport à l'état de la technique, et est de grande valeur pour l'optimisation et le développement de médicaments à l'avenir.
Patent CA-3222894-A1 (CA)
Title: Flush mount lighting fixture
Inventor: FEIT ALAN BARRY
IPC: F21V21/04
Filed: 2017-09-20
Abstract: In an example embodiment, a lighting fixture comprising a lighting device and a mounting bracket is provided. The lighting device compriscs a front cover, a back cover, a frame, and at least one LED mounted within the interior of the lighting device. The frame has an interior edge that is in contact with a perimeter of the front cover and a perimeter of the back cover. The front cover, the back cover, and the frame define the interior of the lighting device. At least one of the frame and the back cover comprises one or more attachment mechanisms. The mounting bracket comprises a junction box mounting element configured for securing the mounting bracket to a junction box or a mounting surface, and one or more attachment mechanism mating elements configured to mate with the one or more attachment mechanisms when the lighting device is rotated within the mounting bracket to secure the lighting device into the mounting bracket.
Patent CA-3223198-A1 (CA)
Inventor: BENNI PAUL B
IPC: A61B5/145
Filed: 2022-07-05
Abstract: A method of and system for non-invasively measuring tissue hemoglobin of a subject is provided. The method includes: a) non-invasively sensing tissue of a subject using a near infrared spectrophotometric (NIRS) sensing device, and determining at least one NIRS tissue THb value based on the non- invasive sensing; b) determining whether at least one Hb confounding factor is present during the non-invasive tissue sensing with the NIRS sensing device; and c) determining a NIRS circulatory THb portion of the NIRS tissue THb value based on the presence of the at least one Hb confounding factor during the non-invasive tissue sensing with the NIRS sensing device.
Patent CA-3224208-A1 (CA)
Title: A method for determining at least one property of an aluminium production bath in of an aluminium production cell, a system for determining the at least one property, and a probe for capturing a sample from the aluminium production cel
Inventor: DIAZ CLARO ANTONIO NODA
IPC: G01N25/04
Filed: 2022-07-01
Abstract: The invention regards a method for determining at least one property of an electrolytic bath of an aluminium production cell, the method comprising the steps of lowering a probe into a bath of an aluminium production cell for collecting a sample of the bath by the probe, removing the probe with the sample, recording a series of images of the probe with the sample, and calculating obtaining at least one property based on the recorded series of images.
Patent CA-3226944-A1 (CA)
Title: Tunnel boring machine and method for tunneling using a tunnel boring machine
Inventor: WEHRMEYER GERHARD
Filed: 2022-09-22
Abstract: The invention relates to a tunnel boring machine (103), wherein the driving presses (109) acting on a cutting wheel (106) are controlled by means of the direct input of coordinate values of a desired total centre of pressure (151) in a coordinate system (154, 157) relating to the tunnel boring machine (103). This results in it being relatively simple for a machine operator to control the tunnel boring machine (103).
Patent WO-9012591-A1 (WO)
Inventor: SCHRYVERS ANTHONY BERNARD
IPC: A61K39/095
Filed: 1990-04-26
Abstract: This invention provides methods for isolating and purifying transferrin and lactoferrin receptor proteins from bacterial pathogens by affinity chromatography and provides the preparation of vaccine antigens comprising the purified transferrin and lactoferrin receptor proteins.
Patent WO-9507609-A1 (WO)
Title: Canne a peche perforee
Inventor: HARE GERARD M
IPC: A01K87/00
Filed: 1994-09-15
Abstract: Canne à pêche dans laquelle la ligne (5) passe à travers un axe creux (1) présentant de multiples perforations (10, 11) espacées sur la longueur dudit axe (1) et ayant pour objet de réduire l'humidité dans l'axe et par là, le frottement et la résistance entre la ligne (5) et la surface intérieure de l'axe (1) creux. Ladite surface intérieure dudit axe (1) peut par ailleurs être pourvue de contacts réduisant les irrégularités et de deux ou plusieurs revêtements: hydrofuges, antifriction, antiusure et/ou de renforcement, améliorant certaines propriétés telles que la dispersion de l'eau, la réduction du frottement, et la résistance structurelle de la canne.
Patent WO-9724854-A1 (WO)
Title: Systeme de generation d'exceptions en fonction du trafic des appels
Inventor: KAYALIOGLU INANC
IPC: H04M3/10
Filed: 1996-12-18
Abstract: Cette invention concerne un système (12) qui va générer un rapport d'exception pour un problème particulier (Log Y) en fonction du trafic des appels. Ce système va compter le nombre de fois où un problème apparaît dans une fenêtre coulissante (200-I, -II) du volume de trafic des appels. Lorsque ce nombre dépasse une valeur seuil, le système va générer un rapport d'exception qui permettra de lancer une action appropriée afin de résoudre le problème.